PEDIATRICS Vol. 68 No. 6 December 1981, pp. 874-879
This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Easton, J.
Right arrow Articles by Bierman, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Easton, J.
Right arrow Articles by Bierman, C. W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of Asthma

James Easton MD, Bettina Hilman MD, Gail Shapiro MD, Miles Weinberger MD, John Anderson MD, Jerome Buckley MD, Peyton Eggleston MD, and C. W. Bierman MD

Advances in the knowledge of clinical pharmacology and pulmonary physiology have significantly improved the management of asthma in children and adolescents. Acute episodes of asthma can be treated with oral bronchodilators if the episodes are mild, but inhaled sympathomimetic drugs are more effective and may have fewer side effects. Effective therapy for status asthmaticus consists of intravenous aminophylline and corticosteroids and aerosolized sympathomimetic drugs. Theophylline, in a dose that maintains serum concentrations between 10 and 20 µg/ml, or cromolyn is the drug of choice for managing asthma when symptoms are continuous or recur frequently. Theophylline appears to be more convenient to use than inhaled cromolyn sodium, after the proper dose is established. However, cromolyn has no risk of overdosage and does not require the measurement of serum concentrations essential for theophylline efficacy and safety. beta-Adrenergic agents are useful adjuncts or alternatives to therapy with theophylline or cromolyn. Treatment by short courses of corticosteroids may be needed at intervals for patients with chronic or labile asthma. Continuous use of corticosteroids will be required for the relatively few patients whose asthma cannot be controlled with other medications. Alternate-day prednisone or inhaled beclomethasone dipropionate offer two alternatives for continuous therapy with corticosteroids which are relatively free from adverse effects of chronic steroid administration. Immunotherapy for inhaled pollens, house dust, or molds may be useful in selected patients whose allergy is clearly exacerbating to their asthma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
J. Levy and G. B. Kolski
The Use of Theophylline Clearance in Pediatric Status Asthmaticus: II. The Choice of Appropriate Dose for the Intravenous Theophylline Infusion
Arch Pediatr Adolesc Med, March 1, 1987; 141(3): 288 - 291.
[Abstract] [PDF]